S. PE POPPY RED 17-1664

900 H/S BASE 9211-17 CARDINAL THERMOSET PLASTISOL

S GREEN W/LM C HSB MAGENTA HIPS #17

Microsoft PowerPoint - Avient Q1 2021 Earnings - Final (For Print) AVIENT CORPORATION F I R S T Q U A R T E R 2 0 2 1 R E S U L T S (NYSE: AVNT) A P R I L 3 0 , 2 0 2 1 D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Develop and implement solutions to end plastic waste while supporting AEPW $1.5B investment in key initiatives. 2 0 3 0 S U STA I NA B I L I T Y TA RG E TS 15 PEER COMPARISONS 16 $442 $457 $560 2019PF 2020PF 2021E $1.74 $1.93 $2.80 2019PF 2020PF 2021E FULL YEAR 2019 – 2021 ORGANIC GROWTH ( T O TA L C O M PA N Y ) 17 Sales Adjusted EBITDA $3,981 $3,783 $4,300 2019PF 2020PF 2021E + 8% Adjusted EPS (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (1) (1) (in millions) (in millions) (1)(1) + 27% + 61% (1) (1) As a specialty formulator, we don’t require significant capital investment, as compared to the base resin raw material suppliers we purchase from. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 20 Avient reflects 2021 estimated EBITDA of $560M O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 10.2 17.7 16.0 14.9 14.6 11.6 11.1 26.7 24.0 22.8 14.3 12.7 11.5 11.2 11.1 11.0 10.3 10.1 9.5 9.4 8.3 7.0 A vi e n t K W R A V Y R P M P P G G C P F U L A L B H X L E C L IF F F M C B N R A S H G R A F O E S C L E M N U N V R C E K R A H U N Median: 11.1xMedian: 14.8x S U M M A RY: W H Y I N V E S T I N AV I E N T ?

Microsoft PowerPoint - AVNT Nov Investor Meetings Update AVIENT CORPORATION I N V E S T O R M E E T I N G S (NYSE: AVNT) N O V E M B E R 2 0 2 1 D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Post-consumer recycled content as percentage of total plastic packaging volume, by weight E NA B L I N G T H E U S E O F R E C YC L E D C O N T EN T T O P 5 G A P S T H A T W E A R E A D D R E S S I N G 2) DECONTAMINATION1) COLOR MANAGEMENT 3) MAINTAINING MECHANICAL PROPERTIES 4) MONO-MATERIAL CONSTRUCTION 5) CONSISTENT RECYCLED MATERIAL QUALITY 15 G U I D I N G B R A N D S T O W H A T I S P O S S I B L E C A S E S T U DY W I T H B R A N D OW N E R Recycled ResinVirgin Resin 16 S U S TA I NA B I L I T Y F O R A B ET T E R TO M O R ROW 17 • Revenue from sustainable solutions expected to grow 18% in 2021 as our innovation efforts and collaboration with customers continues to accelerate • Investments centered around innovation and global sustainability megatrends o Enabling a circular economy – Technologies that allow for increased use of post-consumer recycled (PCR) material and improve recyclability of plastics o Light-weighting – Composites and CAI applications to reduce weight and material requirements, which minimize energy and carbon emissions o Eco-Conscious – Health and human safety applications as well as Avient’s alternative materials to replace lead, PVC, halogens, BPA and other less eco-friendly options 17 *Avient Sustainable Solutions definitions aligned with FTC 2012 Guide for the Use of Environmental Marketing Claims (“Green Guides”) **2020 is Pro Forma to include full year of the Clariant Color business 2016 2017 2018 2019 2020PF** 2021E $405M $455M $340M $550M $790M Revenue From Sustainable Solutions* 2016-2021 $930M 17 Q3 2020 $925 $74 Sustainable Solutions 35 19% 14 Healthcare 51 44% 10 Composites 13 39% 6 Growth in Asia / LATAM 14 11% 3 Other 177 39% 16 Sub-total $1,215 31% $123 Supply Chain Disruption Costs (19) COVID Response Applications (5) (3) FX Impact 10 2 Synergies 12 Incentives, Travel, Other Employee Costs (16) Q3 2021 $1,220 32% $99 Q3 2021 SALES AND OPERATING INCOME ( T O TA L C O M PA N Y ) 18 Sales Growth Rate Adjusted Operating Income$ millions 19 Q3 2020 Q3 2021 (1) Financial information is presented on a constant currency basis (1) (44% of total revenue) (56% of total revenue) Q3 END MARKET SALES PERFORMANCE +20% +31% +40% +24% +46% +40% +14% +33% Energy Telecom Building & Construction Transportation Industrial Healthcare Packaging Consumer Q3 YEAR-OVER-YEAR EBITDA BRIDGE 20 • Demand driven by growth in sustainable solutions, healthcare and consumer applications • Price increases more than offsets raw material and supply chain impacts • Synergy capture on pace to achieve $50M in annual savings in 2021 Q3 2020 $ 111 Demand 29 Adjusted EBITDA$ millions CAI: Price / Mix 51 Inflation (37) SEM: Price / Mix 25 Inflation (22) Distribution: Price / Mix 108 Inflation (103) Net Price Benefit 22 Supply Chain Disruption Costs (19) COVID Response Applications (3) Synergies 12 Incentives, FX, Other (16) Q3 2021 $ 136     21 • Price increases have more than covered raw material and freight inflation impacts of $300M year- to-date compared to 2020 • Demand impact driven by Q3 seasonality for the business Q2 TO Q3 SEQUENTIAL EBITDA BRIDGE Q2 2021 $ 159 CAI: Price / Mix 17 Inflation (8) SEM: Price / Mix 6 Inflation (5) Distribution: Price / Mix 35 Inflation (35) Net Price Benefit 10 Supply Chain Disruption Costs (4) Demand / Seasonality (35) Other 6 Q3 2021 $ 136 Adjusted EBITDA$ millions     F U L L Y E A R 2 0 2 1 O U T L O O K $308 $430 2020PF 2021E $1.93 $3.00 2020PF 2021E FULL YEAR GROWTH PROJECTIONS ( T O TA L C O M PA N Y ) 23 Sales Adjusted Operating Income $3,783 $4,750 2020PF 2021E + 26% Adjusted EPS + 40% + 55% (in millions) (in millions) (1) Financial information is pro forma to include a full year of Clariant Color acquisition (1)(1)(1) $1.74 $1.93 $3.00 2019PF 2020PF 2021E $442 $457 $580 2019PF 2020PF 2021E FULL YEAR 2019 – 2021 GROWTH ( T O TA L C O M PA N Y ) 24 Sales Adjusted EBITDA $3,981 $3,783 $4,750 2019PF 2020PF 2021E + 19% Adjusted EPS (1) Financial information is pro forma to include a full year of Clariant Color acquisition (1) (1) (in millions) (in millions) (1)(1) + 31% + 72% (1) (1) 0.1 0.1 0.2 0.5 0.6 0.7 0.8 0.9 0.9 1.0 1.0 11 12 13 14 15 16 17 18 19 20 21 40% 99% YTD 5 - YR 10 - YR 0.16 0.20 0.26 0.34 0.42 0.50 0.58 0.72 0.79 0.81 0.85 0.95 11 12 13 14 15 16 17 18 19 20 21 22 2.1x Q4 NET LEVERAGE ~$1Bn REPURCHASED OVER LAST 10 YEARS ~$450MM PAID OVER LAST 11 YEARS C R E AT I N G VA LU E F O R SH A R E H O L D E R S 25 Share Performance Dividends Share Repurchases Deleveraging 3.5x 2.1x 2019PF 2021E Growing Dividend Cumulative Buybacks Net Leverage $ B n $ p e r sh a re Total Shareholder Return ~$4Bn MARKET CAP INCREASE OVER LAST 10 YEARS (1) Share performance includes reinvested dividends and is as of 10.25.2021 (2) Financial information is pro forma to include a full year of Clariant Color acquisition (1) (2) 494% SUSTA INAB ILITY R EPORT Continuous ESG Improvement 26 • Updated 2030 Sustainability Goals • Further disclosure on key Environmental, Social, and Governance impacts • Joined U.N. With the Clariant Color business acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 33 Avient reflects 2021 estimated EBITDA of $580M O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 11.4 20.2 16.7 16.5 14.7 12.0 10.8 40.7 29.9 26.2 13.2 12.4 11.0 10.9 9.1 9.0 7.5 6.5 A vi e n t K W R P P G A V Y R P M F U L G C P A L B H X L E C L A S H F M C B N R S C L U N V R E M N C E H U N S U M M A RY: W H Y I N V E S T I N AV I E N T ?

Microsoft PowerPoint - AVNT Mar 2022 Presentation AVIENT CORPORATION I N V E S T O R M E E T I N G S (NYSE: AVNT) M A R C H 2 0 2 2 D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. D is t. ) K W R P P G F U L R P M A V Y F M C H U N H X L S C L E C L E M N C E A S H Source: Peer data per Bloomberg market data as of February 15, 2022. O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 5.4 8.5 10.1 10.0 15.7 15.0 14.2 12.7 10.2 25.0 19.7 17.7 13.2 12.3 10.0 9.9 8.9 8.5 8.3 6.6 A vi e n t (2 0 1 1 ) A vi e n t (2 0 1 6 ) A vi e n t (2 0 2 1 ) A vi e n t (T o d a y) R P M K W R P P G A V Y F U L A L B E C L H X L A S H F M C B N R E M N U N V R C E S C L H U N Historic Multiple S U M M A RY: W H Y I N V E S T I N AV I E N T ?

17

February 17, 2025

March 17, 2016

Empty totes can stack up to 17 high while folded.